Emboline Prevails in German Utility Model Infringement Action Against AorticLab

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Emboline-AorticLab

More Like This

Emboline, Inc. Files Patent Infringement Suit Against AorticLab s.r.l. Regarding Embolic Protection Medical Device

PR Newswire associated0

Emboline, Inc. Secures $20 Million in Growth Capital from Trinity Capital Inc. to Support Commercialization of the Emboliner® Embolic Protection System to Minimize Stroke Risk From TAVR

Emboline, Inc. Completes Enrollment in U.S. Pivotal IDE Trial of the Emboliner® Embolic Protection Catheter Designed to Protect Patients from Embolic Injury During Transcatheter Aortic Valve Replacement

PR Newswire associated0

Emboline Announces Positive Pivotal PROTECT H2H Trial Results for Emboliner® Presented as a Late-Breaking Clinical Trial at ACC 2026

PR Newswire associated0

AorticLab S.r.l. Announces Clear Victory Before the European Unified Patent Court in Litigation Brought by Emboline, Inc.

Protembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Study

The ProtEmbo Cerebral Embolic Protection system in the Aortic Arch (Graphic: Business Wire)

German Medtech Protembis Gets €20 Million EIB Backing for Technology to Protect Brain During Heart Treatment

Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors